Related Experiment Video
Updated: Jan 9, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Five-year Outcomes of Transcatheter Aortic Valve Replacement Versus Surgery in Low-risk Aortic Stenosis: Insights
Saliha Erdem1, Sachin S Goel1, Michael J Reardon1
1Houston Methodist Hospital, DeBakey Heart and Vascular Institute, Houston, TX, USA.
Abstract:
The Evolut Low Risk trial (Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement; ClinicalTrials.gov identifier: NCT02701283) provides reassuring evidence that transcatheter aortic valve replacement remains non-inferior to surgery at 5-year follow-up with regard to mortality and disabling stroke in low-risk patients. Valve performance, durability and quality-of-life improvements were excellent in both groups.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse III: Nursing Management

